Association of the FTO and ADRB2 genes with body composition and fat distribution in obese women

Maturitas

Volumn 76, Issue 2, 2013, Pages 165-171

  Rauhio, Anne ^a   Uusi Rasi, Kirsti ^b   Nikkari, Seppo T ^a,c   Kannus, Pekka ^b,d   Sievänen, Harri ^b   Kunnas, Tarja ^c  

^a FIMLAB LABORATORIES   (Finland)

^b UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

DXA; Genetic variants; Obesity; Weight maintenance; Weight reduction

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; FAT MASS AND OBESITY ASSOCIATED PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADRB2 GENE; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FTO GENE; GENE; HIP CIRCUMFERENCE; HOMOZYGOTE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

A; ADENINE; ADRB2; BMI; BODY MASS INDEX; DUAL-ENERGY X-RAY ABSORPTIOMETRY; DXA; FAT MASS AND OBESITY-ASSOCIATED GENE; FTO; GENERAL LINEAR MODEL; GENETIC VARIANTS; GLM; GLN; GLU; GLUTAMIC ACID; GLUTAMINE; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; T; THYMINE; VERY-LOW-ENERGY DIET; VLED; WEIGHT MAINTENANCE; WEIGHT REDUCTION; Β2-ADRENERGIC RECEPTOR GENE;

ADULT; BODY COMPOSITION; BODY MASS INDEX; DNA; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTORS, ADRENERGIC, BETA-2; WEIGHT LOSS;

EID: 84888638039     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.07.004     Document Type: Article

References (30)

1. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209.
2. Day FR, Loos RJ. Developments in obesity genetics in the era of genomewide association studies. Journal of Nutrigenetics and Nutrigenomics 2011;4:222-38.
3. Fawcett KA, Barroso I. The genetics of obesity: FTO leads the way. Trends in Genetics 2010;26:266-74.
4. Leibel RL. Energy in, energy out, and the effects of obesity-related genes. New England Journal of Medicine 2008;359:2603-4.
5. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-94.
6. Qi L, Kang K, Zhang C, et al. Fat mass- and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Diabetes 2008;57:3145-51.
7. Mei H, Chen W, Srinivasan SR, et al. FTO influences on longitudinal BMI over childhood and adulthood and modulation on relationship between birth weight and longitudinal BMI. Human Genetics 2010;128:589-96.
8. Kaakinen M, Laara E, Pouta A, et al. Life-course analysis of a fat mass and obesityassociated (FTO) gene variant and body mass index in the Northern Finland Birth Cohort 1966 using structural equation modeling. American Journal of Epidemiology 2010;172:653-65.
9. Razquin C, Martinez JA, Martinez-Gonzalez MA, Bes-Rastrollo M, Fernandez- Crehuet J, Marti A. A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes. International Journal of Obesity 2010;34:266-72.
10. Hertel JK, Johansson S, Sonestedt E, et al. FTO, type 2 diabetes, and weight gain throughout adult life: A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 2011;60:1637-44.
11. Wahlen K, Sjolin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. Journal of Lipid Research 2008;49:607-11.
12. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring) 2008;16:1961-5.
13. Jacobsson JA, Riserus U, Axelsson T, Lannfelt L, Schioth HB, Fredriksson R. The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924. BMC Medical Genetics 2009;10:131.
14. Muller TD, Hinney A, Scherag A, et al. 'Fat mass and obesity associated? Gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Medical Genetics 2008;9:85.
15. Large V, Hellstrom L, Reynisdottir S, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Journal of Clinical Investigation 1997;100:3005-13.
16. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. Journal of Internal Medicine 1999;245: 253-9.
17. Lange LA, Norris JM, Langefeld CD, et al. Association of adipose tissue deposition and beta-2 adrenergic receptor variants: The IRAS family study. International Journal of Obesity 2005;29:449-57.
18. Gjesing AP, Andersen G, Burgdorf KS, et al. Studies of the associations between functional beta2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7808 white subjects. Diabetologia 2007;50: 563-8.
19. Jalba MS, Rhoads GG, Demissie K. Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: A meta-analysis. Obesity (Silver Spring) 2008;16:2096-106.
20. Ruiz JR, Larrarte E, Margareto J, Ares R, Labayen I. Role of beta-adrenergic receptor polymorphisms on body weight and body composition response to energy restriction in obese women: Preliminary results. Obesity (Silver Spring) 2011;19:212-5.
21. Uusi-Rasi K, Rauhio A, Kannus P, et al. Three-month weight reduction does not compromise bone strength in obese premenopausal women. Bone 2010;46:1286-93.
22. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. International Journal of Obesity and Related Metabolic Disorders 2000;24:382-7.
23. Gonzalez Sanchez JL, Proenza AM, Martinez Larrad MT, et al. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: A population-based study in Spain. Clinical Endocrinology (Oxford) 2003;59:476-81.
24. Kunnas T, Lahtio R, Kortelainen ML, Kalela A, Nikkari ST. Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women. Lipids in Health and Disease 2009;8:43.
25. Andreasen CH, Stender-Petersen KL, Mogensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2008;57:95-101.
26. Mangge H, Renner W, Almer G, Weghuber D, Moller R, Horejsi R. Rs9939609 variant of the fat mass and obesity-associated gene and trunk obesity in adolescents. Journal of Obesity 2011;2011:186368.
27. Kilpelainen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children. PLoS Medicine 2011;8(11):e1001116.
28. Fogelholm M, Kukkonen-Harjula K. Does physical activity prevent weight gain - a systematic review. Obesity Reviews 2000;1:95-111.
29. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: A systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. Journal of the American Dietetic Association 2007;107: 1755-67.
30. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999;353:896.